PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREVENTING, TREATING, OR INHIBITING INFLAMMATORY DISEASES, DISORDERS, OR CONDITIONS OF THE SKIN, AND DISEASES, DISORDERS, OR CONDITIONS ASSOCIATED WITH COLLAGEN DEPLETION
申请人:CHANG Chien-Neng
公开号:US20090010884A1
公开(公告)日:2009-01-08
The present invention provides compositions and methods for preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion using one or more estrogenic agents.
SUBSTITUTED 2-PHENYL BENZOFURANS AS ESTROGENIC AGENTS
申请人:Wyeth
公开号:EP1458700A2
公开(公告)日:2004-09-22
US6774248B2
申请人:——
公开号:US6774248B2
公开(公告)日:2004-08-10
US7022733B2
申请人:——
公开号:US7022733B2
公开(公告)日:2006-04-04
[EN] SUBSTITUTED 2-PHENYL BENZOFURANS AS ESTROGENIC AGENTS<br/>[FR] 2-PHENYL BENZOFURANES SUBSTITUES COMME AGENTS OESTROGENIQUES
申请人:WYETH CORP
公开号:WO2003051860A2
公开(公告)日:2003-06-26
This invention provides estrogen receptor modulators of formula I, having the structure (formula I) wherein P and P’ are each, independently, hydrogen, alkyl of 1-6 carbon atoms, or acyl of 2-7 carbon atoms; X is hydrogen or halogen; R is hydrogen, alkyl of 1-6 carbon atoms, halogen, -CN, or-CHO; R’ is alkoxy of 1-6 carbon atoms, or cyanoalkyl having 1-6 carbon atoms in the alkyl moiety; or a pharmaceutically acceptable salt thereof.